Albemarle Corporation
$93.65
−3.31 · −3.41% today
Market open · updated 12:44:26 PM ET
- High
- $97.94 9:35 AM
- Low
- $95.50 6:30 AM
Against the S&P 500 Price change through Oct 27, 2026
ALB−30.03%
S&P 500+12.87%
ALB+2.84%
S&P 500+12.32%
ALB−26.39%
S&P 500+87.41%
ALB−57.30%
S&P 500+69.55%
Key numbers
- Previous close
- $96.96
- Open
- $94.96
- Day's range
- $93.26 – $95.02
- 52-week range
- $88.01 – $221.00
- Volume
- 877,591
- Average volume
- 2.4 million
- Market value
- $11.1 billion
- Price to earnings
- 194.6last 12 months
- Earnings per share
- $1.90last 12 months
- Beta
- 1.36moves about 1.4× as much as the market
- Dividend
- $1.63 a year · 1.74%
- 50-day average
- $113.53
- 200-day average
- $150.83
Wednesday, Nov 4, 2026, after the close.
Analyst price targets and the full financials are in the terminal.
Albemarle in the news
No desk stories on ALB yet. When we write about it, the story leads this list.
- HeadlineAlbemarle (ALB) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research · October 28, 2026 at 11:02 AM ET
- HeadlineHere's Why Albemarle (ALB) is a Strong Value StockZacks Investment Research · October 27, 2026 at 10:41 AM ET
- HeadlineInvestors Heavily Search Albemarle Corporation (ALB): Here is What You Need to KnowZacks Investment Research · October 27, 2026 at 10:01 AM ET
- HeadlineAlbemarle Announces Quarterly Common Stock DividendPRNewsWire · October 26, 2026 at 4:15 PM ET
- HeadlineAlbemarle (ALB) Gains As Market Dips: What You Should KnowZacks Investment Research · October 23, 2026 at 6:50 PM ET
- HeadlineAlbemarle (ALB) Suffers a Larger Drop Than the General Market: Key InsightsZacks Investment Research · October 22, 2026 at 7:01 PM ET
- HeadlineAlbemarle (ALB) Sees a More Significant Dip Than Broader Market: Some Facts to KnowZacks Investment Research · October 16, 2026 at 6:51 PM ET
- CongressRo Khanna bought $1,001 - $15,000 of ALBHouse filing · disclosed Oct 9, 2026
Earnings
Next report: Wednesday, Nov 4, 2026, after the close.
Congress trades in ALB
3 purchases and 3 sales in the latest 6 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Ro KhannaHouse · D-California | Purchase | $1,001 - $15,000 | Sep 25, 2026 | Oct 9, 2026 |
| John BoozmanSenate · R-Arkansas | Purchase | $1,001 - $15,000 | May 15, 2026 | Jun 16, 2026 |
| Jefferson ShreveHouse · R-Indiana | Sale | $15,001 - $50,000 | May 12, 2025 | Jun 23, 2025 |
| Jefferson ShreveHouse · R-Indiana | Purchase | $15,001 - $50,000 | Apr 7, 2025 | May 9, 2025 |
| Julie JohnsonHouse · D-Texas | Sale | $1,001 - $15,000 | Feb 12, 2025 | Mar 13, 2025 |
| Jefferson ShreveHouse · R-Indiana | Sale | $15,001 - $50,000 | Feb 24, 2025 | Mar 10, 2025 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About Albemarle
Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium.
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Employees
- 7,800
- Headquarters
- Charlotte, North Carolina
- Website
- albemarle.com
- Listed
- Feb 22, 1994
More chemicals - specialty stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.